A phase III double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

A prospective observational study of artificial intelligence based radiotherapy treatment planning for cervical, head and neck and prostate cancer

Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A meta-analysis of aggregate data

REduced Frequency ImmuNE checkpoint inhibition in cancers

Studying Treatments in patients receiving androgen deprivation therapy (ADT) and androgen receptor signalling inhibitors (ARSI) for Metastatic Prostate Cancer: Evaluation of Drug and radiation Efficacy: A 2nd multi-arm multi-stage randomised controlled trial (STAMPEDE2).

Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer

UKCTOCS Longitudinal Women’s Cohort